View all research projects
Research project

Targeting natural killer cell receptors for immunotherapeutic benefit

Staff

Lead researchers

Professor Salim Khakoo

Professor of Hepatology
Connect with Salim

Email: [email protected]

Other researchers

Dr Ali Roghanian PhD, FHEA

Associate Professor

Research interests

  • Cancer immunotherapy
  • Monoclonal antibodies
  • Cellular therapies (e.g., CAR T and iNKT cells)
Connect with Ali

Email: [email protected]

Research outputs

KIR2DS2 expression identifies NK cells with enhanced anticancer activity
Matthew Blunt, Mark Cragg, Amber Doyle, Jack, Graham Fisher, Salim Khakoo, Francesco Forconi, Peter Johnson, Marta Ewa Polak, Lara, Victoria Graham, Andres Vallejo Pulido, Rebecca Fulton & Matthew Carter, 2022, The Journal of Immunology, 209 (2)(2), 379-390
DOI: 10.4049/jimmunol.2101139
Type: article
Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQ beta 1
Ana Valencia, Candelaria Vergara, Chloe L Thio, Nicolas Vince, Venceslas Douillard, Alba Grifoni, Andrea L Cox, Eric O Johnson, Alex H Kral, James J Goedert, Alessandra Mangia, Valeria Piazzolla, Shruti H Mehta, Gregory D Kirk, Arthur Y Kim, Georg M Lauer, Raymond T Chung, Jennifer C Price, Salim I Khakoo, Laurent Alric, Matthew E Cramp, Sharyne M Donfield, Brian R Edlin, Michael P Busch, Graeme Alexander, Hugo R Rosen, Edward L Murphy, Genevieve L Wojcik, Mary Carrington, Pierre-Antoine Gourraud, Alessandro Sette, David L Thomas & Priya Duggal, 2022, American Journal of Human Genetics, 109(2), 299-310
DOI: 10.1016/j.ajhg.2022.01.001
Type: article
Selinexor enhances NK cell activation against malignant B cells via downregulation of HLA-E
Jack, Graham Fisher, Salim Khakoo, Mark Cragg, Francesco Forconi, Peter Johnson, Amber Doyle, christopher Walker, yosef landesman & Matthew Blunt, 2021, Frontiers in Oncology
DOI: 10.3389/fonc.2021.785635
Type: article
The role of NK cells in oncolytic viral therapy
Frazer Warricker, Salim I. Khakoo & Matthew D. Blunt, 2021, Journal of Translational Genetics and Genomics, 5, 304-322
DOI: 10.20517/jtgg.2021.27
Type: article
A peptide: MHC based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
Salim Khakoo, Pauline E Rettman, Matthew Blunt, Rebecca Fulton, Andres Vallejo Pulido, Leidy Bastidas Legarda, Laura Espana-Serrano, Marta Polak, Aymen Al-Shamkhani & Christelle Retiere, 2021, Journal for Immunotherapy of Cancer, 9(5)
DOI: 10.1136/jitc-2020-001912
Type: article